Contralateral suppression of transient-evoked otoacoustic emissions in children with sickle cell disease

Ear and Hearing

Volumn 33, Issue 3, 2012, Pages 421-429

  Stuart, Andrew ^a   Preast, June L ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; AUDITORY NERVOUS SYSTEM; AUDITORY STIMULATION; AUDITORY THRESHOLD; CHILD; COCHLEAR NUCLEUS; EVOKED BRAIN STEM AUDITORY RESPONSE; FEMALE; GENETICS; HAIR CELL; HEARING; HEMISPHERIC DOMINANCE; HOMOZYGOTE; HUMAN; MALE; METHODOLOGY; OLIVARY NUCLEUS; PATHOPHYSIOLOGY; PERCEPTION DEAFNESS; PHYSIOLOGY; PURE TONE AUDIOMETRY; SICKLE CELL ANEMIA; SPONTANEOUS OTOACOUSTIC EMISSION;

ACOUSTIC STIMULATION; ADOLESCENT; ANEMIA, SICKLE CELL; AUDIOMETRY, PURE-TONE; AUDITORY PATHWAYS; AUDITORY PERCEPTION; AUDITORY THRESHOLD; CHILD; COCHLEAR NUCLEUS; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; FEMALE; FUNCTIONAL LATERALITY; HAIR CELLS, AUDITORY, OUTER; HEARING LOSS, SENSORINEURAL; HOMOZYGOTE; HUMANS; MALE; OLIVARY NUCLEUS; OTOACOUSTIC EMISSIONS, SPONTANEOUS;

EID: 84860833576     PISSN: 01960202     EISSN: None     Source Type: Journal    
DOI: 10.1097/AUD.0b013e31823effd9     Document Type: Article

References (86)

1. Adams, P. F., Benson, V. (1992). Current estimates from the National Health Interview Survey, 1991. Vital Health Stat, 10, 1-232.
2. Aderibigbe, A., Ologe, F.E., Oyejola, B.A. (2005). Hearing thresholds in sickle cell anemia patients: emerging new trends? J Natl Med Assoc, 97, 1135-1142. (Pubitemid 41098541)
3. Agrup, C., & Luxon, L. M. (2006). Immune-mediated inner-ear disorders in neuro-otology. Curr Opin Neurol, 19, 26-32. (Pubitemid 43172702)
4. Ajulo, S. O., Osiname, A. I., Myatt, H. M. (1993). Sensorineural hearing loss in sickle cell anaemia-A United Kingdom study. J Laryngol Otol, 107, 790-794. (Pubitemid 23289730)
5. American National Standards Institute. (1996). ANSI S3.6-1996. Specification for audiometers. New York: American National Standards Institute.
6. American National Standards Institute. (2003). ANSI S3.1-1999 (R2003). Maximum permissible ambient noise levels for audiometric test rooms. New York: American National Standards Institute.
7. American Speech-Language-Hearing Association. (2005). Guidelines for Manual Pure-Tone Threshold Audiometry [Guidelines]. Rockville, MD: American Speech-Language-Hearing Association. Available from www. asha.org/policy. DOI: 10.1044/policy.GL2005-00014.
8. American Speech-Language-Hearing Association Audiologic Assessment Panel 1996.(1997). Guidelines for Audiologic Screening. Rockville, MD: American Speech-Language-Hearing Association.
9. Angeli, M. L., Almeida, C. I., Sens, P. M. (2008). Comparative study between school performance on first grade children and suppression of otoacoustic transient emission. Braz J Otorhinolaryngol, 74, 112-117.
10. Ashley-Koch, A., Yang, Q., Olney, R. S. (2000). Sickle hemoglobin (HbS) allele and sickle cell disease: A HuGE review. Am J Epidemiol, 151, 839-845. (Pubitemid 30461125)
11. Ashoor, A., & Al-Awamy, B. (1985). Sensorineural hearing loss in sickle cell disease patients in Saudi Arabia. Trop Geogr Med, 37, 314-318. (Pubitemid 16227232)
12. Atsina, K., & Ankra-Badu, G. (1988). Sensorineural hearing loss in Ghanaians with sickle cell anaemia. Trop Geogr Med, 40, 205-208.
13. Berlin, C. I., Hood, L. J., Cecola, R. P., et al. (1993). Does type I afferent neuron dysfunction reveal itself through lack of efferent suppression? Hear Res, 71, 1-11.
14. Berlin, C. I., Hood, L. J., Hurley, A., et al. (1994). The First Jerger Lecture. Contralateral suppression of otoacoustic emissions: An index of the function of the medial olivocochlear system. Otolaryngol Head Neck Surg, 110, 3-21. (Pubitemid 24054839)
15. Berlin, C. I., Hood, L. J., Hurley, A. E., et al. (1995). Binaural noise suppresses linear click-evoked otoacoustic emissions more than ipsilateral or contralateral noise. Hear Res, 87, 96-103.
16. Buniel, M. C., Geelan-Hansen, K., Weber, P. C., et al. (2009). Immunosuppressive therapy for autoimmune inner ear disease. Immunotherapy, 1, 425-434.
17. Burch-Sims, G. P., & Matlock, V. R. (2005). Hearing loss and auditory function in sickle cell disease. J Commun Disord, 38, 321-329. (Pubitemid 40615983)
18. Burguetti, F. A., & Carvallo, R. M. (2008). Efferent auditory system: Its effect on auditory processing. Braz J Otorhinolaryngol, 74, 737-745.
19. Clarke, E. M., Ahmmed, A., Parker, D., et al. (2006). Contralateral suppression of otoacoustic emissions in children with specific language impairment. Ear Hear, 27, 153-160. (Pubitemid 44378658)
20. Cohen, J. (1988). Statistical Power Analysis for the Behavioral Sciences (2nd ed.). Hillsdale, NJ: Erlbaum.
21. Cohen, J. (1990). Things I have learned (so far). Am Psychol, 45, 1304-1312.
22. Cohen, J. (1994). The earth is round (p,.05). Am Psychol, 49, 997-1003.
23. Crawford, M. R., Gould, H. J., Smith, W. R., et al. (1991). Prevalence of hearing loss in adults with sickle cell disease. Ear Hear, 12, 349-351.
24. Di Girolamo, S., Napolitano, B., Alessandrini, M., et al. (2007). Experimental and clinical aspects of the efferent auditory system. Acta Neurochir Suppl, 97, 419-424.
25. Dorn, P. A., Piskorski, P., Keefe, D. H., et al. (1998). On the existence of an age/threshold/frequency interaction in distortion product otoacoustic emissions. J Acoust Soc Am, 104, 964-971. (Pubitemid 28373183)
26. Downs, C. R., Stuart, A., Holbert, D. (2000). Distortion product otoacoustic emissions in normal-hearing children with homozygous sickle cell disease. J Commun Disord, 33, 111-129. (Pubitemid 30243121)
27. Drexl, M., Henke, J., Ksl, M. (2004). Isoflurane increases amplitude and incidence of evoked and spontaneous otoacoustic emissions. Hear Res, 194, 135-142. (Pubitemid 38987862)
28. Elion, J. E., Brun, M., Odievre, M. H., et al. (2004). Vaso-occlusion in sickle cell anemia: Role of interactions between blood cells and endothelium. Hematol J, 5 (Suppl. 3), S195-S198. (Pubitemid 39077304)
29. Fielding, E. D., & Rawool, V. W. (2002). Acoustic reflex thresholds at varying click rates in children. Int J Pediatr Otorhinolaryngol, 63, 243-252. (Pubitemid 34462137)
30. Forman-Franco, B., Karayalcin, G., Mandel, D. D., et al. (1982). The evaluation of auditory function in homozygous sickle cell disease. Otolaryngol Head Neck Surg, 89, 850-856. (Pubitemid 13195785)
31. Friedman, E. M., Herer, G. R., Luban, N. L., et al. (1980). Sickle cell anemia and hearing. Ann Otol Rhinol Laryngol, 89, 342-347. (Pubitemid 10035348)
32. Gentry, B., Davis, P., Dancer, J. (1997). Failure rates of young patients with sickle cell disease on a hearing screening test. Percept Mot Skills, 84, 434. (Pubitemid 127734743)
33. Guinan J. J.,Jr. (2006). Olivocochlear efferents: Anatomy, physiology, function, and the measurement of efferent effects in humans. Ear Hear, 27, 589-607. (Pubitemid 44691223)
34. Guinan J. J., Jr., Backus, B. C., Lilaonitkul, W., et al. (2003). Medial olivocochlear efferent reflex in humans: Otoacoustic emission (OAE) measurement issues and the advantages of stimulus frequency OAEs. J Assoc Res Otolaryngol, 4, 521-540. (Pubitemid 38112635)
35. Guinan J. J., Jr., Warr, W. B., Norris, B. E. (1983). Differential olivocochlear projections from lateral vs. medial zones of the superior olivary complex. J Comp Neurol, 221, 358-370. (Pubitemid 14216766)
36. Hall, J. W., & Weaver, T. (1979). Impedance audiometry in a young population. The effect of age, sex, and tympanogram abnormalities. J Otolaryngol, 8, 210-222. (Pubitemid 9218839)
37. Halsey, C., & Roberts, I. A. (2003). The role of hydroxyurea in sickle cell disease. Br J Haematol, 120, 177-186. (Pubitemid 36194165)
38. Haupt, H., Scheibe, F., Ludwig, C. (1993). Changes in cochlear oxygenation, microcirculation and auditory function during prolonged general hypoxia. Eur Arch Otorhinolaryngol, 250, 396-400. (Pubitemid 23337487)
39. Hoenig, J. M., & Heisey, D. M. (2001). The abuse of power: The pervasive fallacy of power calculations for data analysis. Am Stat, 55, 19-24.
40. Homma, K., & Dallos, P. (2011). Dissecting the electromechanical coupling mechanism of the motor-protein prestin. Commun Integr Biol, 4, 450-453.
41. Hood, L. J., Berlin, C. I., Hurley, A., et al. (1996). Contralateral suppression of transient-evoked otoacoustic emissions in humans: Intensity effects. Hear Res, 101, 113-118. (Pubitemid 26386269)
42. Huang, Z. W., Luo, Y., Wu, Z., et al. (2005). Paradoxical enhancement of active cochlear mechanics in long-term administration of salicylate. J Neurophysiol, 93, 2053-2061. (Pubitemid 40404405)
43. Ingram, V. M. (1957). Gene mutations in human haemoglobin: The chemical difference between normal and sickle haemoglobin. Nature, 180, 326-328.
44. Jovanovic-Bateman, L., & Hedreville, R. (2006). Sensorineural hearing loss with brainstem auditory evoked responses changes in homozygote and heterozygote sickle cell patients in Guadeloupe (France). J Laryngol Otol, 120, 627-630. (Pubitemid 44298331)
45. Kakigi, A., Hirakawa, H., Harel, N., et al. (1998). Basal cochlear lesions result in increased amplitude of otoacoustic emissions. Audiol Neurootol, 3, 361-372. (Pubitemid 28438438)
46. Kalluri, R., & Shera, C. A. (2007). Near equivalence of human click evoked and stimulus-frequency otoacoustic emissions. J Acoust Soc Am, 121, 2097-2110. (Pubitemid 46548411)
47. Khalfa, S., Bruneau, N., Rog B., et al. (2001). Peripheral auditory asymmetry in infantile autism. Eur J Neurosci, 13, 628-632. (Pubitemid 32158796)
48. Khalfa, S., Micheyl, C., Veuillet, E., et al. (1998). Peripheral auditory lateralization assessment using TEOAEs. Hear Res, 121, 29-34. (Pubitemid 28319895)
49. Kinsler, L. E., Frey, A. R., Coppens, A. B., et al. (2000). Fundamentals of Acoustics (4th ed.). New York: Wiley.
50. Kirk, R. E. (1996). Practical significance: A concept whose time has come. Educ Psychol Meas, 56, 746-759.
51. Koussi, A., Zafeiriou, D. I., Kontzoglou, G., et al. (2001). Hearing loss in children with sickle cell disease. Acta Otorhinolaryngol Belg, 55, 235-239. (Pubitemid 32938773)
52. Kumar, U. A., & Vanaja, C. S. (2004). Functioning of olivocochlear bundle and speech perception in noise. Ear Hear, 25, 142-146. (Pubitemid 38451763)
53. Liberman, M. C. (1988). Response properties of cochlear efferent neurons: Monaural vs. binaural stimulation and the effects of noise. J Neurophysiol, 60, 1774-1798.
54. Little, R. J. A., & Rubin, D. B. (2002). Statistical Analysis With Missing Data (2nd ed.). New York: Wiley.
55. Lonsbury-Martin, B. L., Martin, G. K., Whitehead, M. L. (1997). Distortion Product Otoacoustic Emissions. In M. S. Robinette & T. J. Glattke (Eds). Otoacoustic Emissions: Clinical Applications (pp. 83-109). New York: Thieme.
56. MacDonald, C. B., Bauer, P. W., Cox, L. C., et al. (1999). Otologic findings in a pediatric cohort with sickle cell disease. Int J Pediatr Otorhinolaryngol, 47, 23-28. (Pubitemid 29093707)
57. Margolis, R. (2002). Distortion Product Otoacoustic Emissions (2nd ed.). In M. S. Robinette & T. J. Glattke (Eds). Otoacoustic Emissions (pp. 190-212). New York: Thieme.
58. Mathews, J., & Kumar, B. N. (2003). Autoimmune sensorineural hearing loss. Clin Otolaryngol Allied Sci, 28, 479-488. (Pubitemid 37491656)
59. Morgenstein, K. M., & Manace, E. D. (1969). Temporal bone histopathology in sickle cell disease. Laryngoscope, 79, 2172-2180.
60. Muchnik, C., Ari-Even Roth, D., Othman-Jebara, R., et al. (2004). Reduced medial olivocochlear bundle system function in children with auditory processing disorders. Audiol Neurootol, 9, 107-114. (Pubitemid 38250529)
61. Odetoyinbo, O., & Adekile, A. (1987). Sensorineural hearing loss in children with sickle cell anemia. Ann Otol Rhinol Laryngol, 96, 258-260. (Pubitemid 17101797)
62. Onakoya, P. A., Nwaorgu, O. G., Shokunbi, W. A. (2010). Hearing impairment in persons with the hemoglobin SC genotype. Ear Nose Throat J, 89, 306-310.
63. Peng, J. H., Tao, Z. Z., Huang, Z. W. (2007). Long-term sound conditioning increases distortion product otoacoustic emission amplitudes and decreases olivocochlear efferent reflex strength. NeuroReport, 18, 1167-1170.
64. Raveh, E., Mount, R. J., Harrison, R. V. (1998). Increased otoacousticemission amplitude secondary to cochlear lesions. J Otolaryngol, 27, 354-360. (Pubitemid 29029027)
65. Ryan, A. F., Harris, J. P., Keithley, E. M. (2002). Immune-mediated hearing loss: Basic mechanisms and options for therapy. Acta Otolaryngol Suppl, 548, 38-43. (Pubitemid 34913453)
66. Sanches, S. G., & Carvallo, R. M. (2006). Contralateral suppression of transient evoked otoacoustic emissions in children with auditory processing disorder. Audiol Neurootol, 11, 366-372. (Pubitemid 44610324)
67. Scheibe, F., Haupt, H., Baumgtl, H. (1997). Effects of experimental cochlear thrombosis on oxygenation and auditory function of the inner ear. Eur Arch Otorhinolaryngol, 254, 91-94. (Pubitemid 27117120)
68. Shera, C. A., & Guinan, J. J., Jr. (1999). Evoked otoacoustic emissions arise by two fundamentally different mechanisms: A taxonomy for mammalian OAEs. J Acoust Soc Am, 105, 782-798.
69. Shera, C. A. (2004). Mechanisms of mammalian otoacoustic emission and their implications for the clinical utility of otoacoustic emissions. Ear Hear, 25, 86-97. (Pubitemid 38451758)
70. Slepecky, N. B., (1996). Structure of the Mammalian Cochlea. In P. Dallos, A. N. Popper, R. R. Fay (Eds.). The Cochlea (pp. 44-129). New York: Springer-Verlag.
71. Song, L., & Santos-Sacchi, J. (2010). Conformational state dependent anion binding in prestin: Evidence for allosteric modulation. Biophys J, 98, 371-637.
72. Stuart, A., Jones, S. M., Walker, L. J. (2006). Insights into elevated distortion product otoacoustic emissions in sickle-cell disease: Comparisons of hydroxyurea-treated and non-treated young children. Hear Res, 212, 83-89. (Pubitemid 43254939)
73. Stuart, M. A., & Nagal, R. L. (2004). Sickle-cell disease. Lancet, 364, 1343-1360.
74. Suzuki, M., & Harris, J. P. (1995). Expression of intercellular adhesion molecule-1 during inner ear inflammation. Ann Otol Rhinol Laryngol, 104, 69-75.
75. Sztuka, A., Pospiech, L., Gawron, W., et al. (2010). DPOAE in estimation of the function of the cochlea in tinnitus patients with normal hearing. Auris Nasus Larynx, 37, 55-60.
76. Todd, G. B., Serjeant, G. R., Larson, M. R. (1973). Sensorineural hearing loss in Jamaicans with sickle cell disease. Acta Otolaryngol, 76, 268-272.
77. Ugur, A. K., Kemaloglu, Y. K., Ugur, M. B., et al. (2009). Otoacoustic emissions and effects of contralateral white noise stimulation on transient evoked otoacoustic emissions in diabetic children. Int J Pediatr Otorhinolaryngol, 73, 555-559.
78. Wagner, W., & Plinkert, P. K. (1999). The relationship between auditory threshold and evoked otoacoustic emissions. Eur Arch Otorhinolaryngol, 256, 177-188. (Pubitemid 29201672)
79. Wake, M., Anderson, J., Takeno, S., et al. (1996). Otoacoustic emission amplification after inner hair cell damage. Acta Otolaryngol, 116, 374-381. (Pubitemid 26000727)
80. Walker, L. J., Stuart, A., Green, W. B. (2004). Outer and middle ear status and distortion product otoacoustic emissions in children with sickle cell disease. Am J Audiol, 13, 164-172.
81. Yalnkaya, F., Yilmaz, S. T., Muluk, N. B. (2010). Transient evoked otoacoustic emissions and contralateral suppressions in children with auditory listening problems. Auris Nasus Larynx, 37, 47-54.
82. Yang, K., Huang, Z. W., Liu, Z. Q., et al. (2009). Long-term administration of salicylate enhances prestin expression in rat cochlea. Int J Audiol, 48, 18-23.
83. Yates, G. K., & Withnell, R. H. (1999). The role of intermodulation distortion in transient-evoked otoacoustic emissions. Hear Res, 136, 49-64. (Pubitemid 29450497)
84. Yu, N., Zhu, M. L., Johnson, B., et al. (2008). Prestin up-regulation in chronic salicylate (aspirin) administration: An implication of functional dependence of prestin expression. Cell Mol Life Sci, 65, 2407-2418.
85. Zhang, C., Huang, W., & Song, H. (2000). Expression of vascular cell adhesion molecule-1, alpha4-integrin and L-selectin during inner ear immunity reaction. Acta Otolaryngol, 120, 607-614. (Pubitemid 32521210)
86. Zheng, J., Shen, W., He, D. Z., et al. (2000). Prestin is the motor protein of cochlear outer hair cells. Nature, 405, 149-155. (Pubitemid 30313525)